http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110592042-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y206-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| filingDate | 2019-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110592042-B |
| titleOfInvention | Transaminase mutants and uses thereof |
| abstract | The invention discloses a transaminase mutant and application thereof. Wherein the amino acid sequence of the transaminase mutant consists of SEQ ID NO:1, the mutation at least comprises one of the following mutation site combinations: T7C + S47C, Q78C + a330C, V137C + G313C, a217C + Y252C and L295C + C328C; or an amino acid sequence of the transaminase mutant which has a mutation site in the mutated amino acid sequence and has an amino acid sequence having 80% or more homology with the mutated amino acid sequence. The transaminase mutant provided by the invention realizes the change of protein structure and function, reduces the enzyme dosage, improves the ee value of the product, reduces the difficulty of post-treatment, and is suitable for industrial production. |
| priorityDate | 2019-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.